Showing results (1-10 of 307) with videos related to
Sort By:
Pageof 31
Diabetes & Vascular Disease Research|July 27, 2007
The endothelium and vascular inflammation in diabetesMartin M Hartge, Thomas Unger, Ulrich KintscherExpert Opinion on Therapeutic Targets|September 11, 2008
Inhibiting angiotensin type 1 receptors as a target for diabetesUlrich Kintscher, Anna Foryst-Ludwig, Thomas UngerEndocrinology and Metabolism Clinics of North America|September 9, 2006
Endothelial dysfunction and its role in diabetic vascular diseaseMartin M Hartge, Ulrich Kintscher, Thomas UngerCirculation|April 4, 2007
Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) studyJürgen Scholze, Elmar Grimm, Dana Herrmann, et al.Circulation|May 1, 2004
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activityMichael Schupp, Jürgen Janke, Ronald Clasen, et al.Chemmedchem|June 9, 2009
Characterization of new PPARgamma agonists: benzimidazole derivatives - the importance of position 2Matthias Goebel, Bart Staels, Thomas Unger, et al.Biochemical and Biophysical Research Communications|May 24, 2003
p38 MAP kinase negatively regulates angiotensin II-mediated effects on cell cycle molecules in human coronary smooth muscle cellsUlrich Kintscher, Dennis Bruemmer, Florian Blaschke, et al.Cardiovascular Diabetology|April 5, 2007
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patientsUlrich Kintscher, Peter Bramlage, W Dieter Paar, et al.Chemmedchem|February 7, 2009
Characterization of new PPARgamma agonists: analysis of telmisartan's structural componentsMatthias Goebel, Markus Clemenz, Bart Staels, et al.Hypertension (Dallas, Tex. : 1979)|July 11, 2018
AT<sub>2</sub>R (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the RatChristoph Lange, Manuela Sommerfeld, Pawel Namsolleck, et al.Pageof 31